Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Natural peptide in sweat may help block flu infection before symptoms start

A naturally produced peptide found in sweat, saliva, tears, and the nasopharynx may help stop influenza before it takes hold, offering a promising new path toward antivirals that target conserved viral weak points with less risk of resistance. A research team

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

A naturally produced peptide found in sweat, saliva, tears, and the nasopharynx may help stop influenza before it takes hold, offering a promising new path toward antivirals that target conserved viral weak points with less risk of resistance.

A research team led by the Fisabio Foundation has demonstrated that dermcidin, a constitutively produced antimicrobial peptide, also exhibits antiviral activity against the influenza virus. The study also shows that people who do not develop flu-like symptoms have higher baseline levels of this molecule, which could be associated with lower susceptibility to infection.

Researchers from CIBERESP, the Institute of Biomedicine of Valencia (IBV-CSIC), and CIBERER, the Institute of Research, Development and Innovation in Healthcare Biotechnology of Elche (IDiBE) of the University Miguel Hernández, the University of Valencia, and Margarita Salas Biological Research Center (CIB-CSIC), among other national and international centers,s have also contributed to the study.

"Dermcidin, which is present in sweat and known for its antibacterial and antifungal activity, also exhibits antiviral activity against the influenza virus and can interfere with infection, as we have observed in in vitro and in vivo models", explains Dr. María D. Ferrer, Miguel Servet researcher and head of the Antimicrobial Peptides and Glycobiology group at Fisabio, who led this study.

"These results show that our own bodies have natural mechanisms capable of curbing viral infection, which opens the door to the development of new, more effective antivirals", notes Dr. Álex Mira, researcher at Fisabio and head of the Oral Microbiome group, who co-directed the study.

Dermcidin Blocks Influenza Cell Entry

The study has demonstrated that dermcidin binds to hemagglutinin, a protein essential for the influenza virus to enter the cell, at a key, highly conserved region involved in the fusion process. This interaction induces a conformational change in the viral protein that impairs the virus's ability to fuse with the cell membrane and, therefore, initiate infection. In this way, dermcidin inactivates the virus before it can infect the cell, through a previously unknown mechanism of action.

This mode of action contrasts with that of most available antivirals, which target neuraminidase, another viral protein, and against which resistance is emerging.

"By acting on regions of the virus that hardly change between subtypes-known as highly conserved regions-dermcidin could contribute to defense against different variants of the influenza virus", explains Dr. Ferrer.

In this sense, Dr. Mira adds that "this same principle could be extended to other respiratory viruses, such as the measles virus and coronaviruses associated with the common cold, suggesting a possible broad-spectrum effect."

Dermcidin Levels in Respiratory Tissues

The team has found that dermcidin is present not only in sweat but also in the main entry points for respiratory viruses into the body, such as the nasopharynx, saliva, and tears.

"The results show that baseline levels of dermcidin are up to six times higher in people who do not develop flu-like symptoms, compared to susceptible individuals", explains Dr. Paula Corell, the study's first author and a member of the team. Furthermore, during a respiratory infection, its concentration increases significantly. "Altogether, these findings reinforce the idea that dermcidin is part of the innate immune system's first line of defense against this type of infection," adds Dr. Corell.

Broad-Spectrum Antiviral Treatment Potential

Researchers note that dermcidin is a promising candidate for developing new strategies to combat respiratory viral infections. In addition to its direct antiviral activity, the team is investigating whether dermcidin may also play an immunomodulatory role, helping regulate the immune system's response to infection.

These findings open new research avenues for the development of antivirals based on the body's natural molecules that target highly conserved viral regions, thereby reducing the likelihood of resistance and enhancing their effectiveness against various respiratory viruses.

Funding Support for Dermcidin Research

This research has received funding from the Valencian Innovation Agency (AVI) through grants INNVAL20/18/005 and INNVAL20/19/006, as well as the INNVA2/2021/3 grant, also funded by the Valencian Innovation Agency (AVI) and the European Union through the European Regional Development Fund (ERDF). Moreover, this research has received support from the Carlos III Health Institute (ISCIII), under grant code CP22/00036, based on the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P., dated December 7, 2022, granting Miguel Servet contracts and additional grants, and co-funded by the European Union. The study has also been funded by the Ministry of Economy and Competitiveness through file SAF2013-505553-EXP.

  • Corell-Escuin, P., Belmonte-Ballester, S., Adhav, A., Marina, A., Gadea-Salom, L., Martinez-Gil, L., Aledavood, E., Fernández-Escamilla, A. M., Gómez Sáez, A., Gougeard, N., Dee, K., Murcia, P. R., Magos, E. A., Llena, C., Peris-Martínez, C., Artacho, A., Mengual-Chuliá, B., López-Labrador, F. X., Mira, A., . . . Ferrer, M. D. (2026). Dermcidin has antiviral activity and protects against influenza. Proceedings of the National Academy of Sciences, 123(14), e2424461123. DOI: 0.1073/pnas.2424461123, https://www.pnas.org/doi/pdf/10.1073/pnas.2424461123

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What are 'dancing molecules'?

Stupp and his team posited that "dancing molecules" might encourage the stubborn tissue to regenerate. Previously invented in Stupp's laboratory, dancing molecules are assemblies that form synthetic nanofibers comprising tens to hundreds of thousands of molecules with potent signals for cells. By tuning their collective motions through their chemical structure, Stupp discovered the moving molecules could rapidly find and properly engage with cellular receptors, which also are in constant motion and extremely crowded on cell membranes. Once inside the body, the nanofibers mimic the extracellular matrix of the surrounding tissue. By matching the matrix's structure, mimicking the motion of biological molecules and incorporating bioactive signals for the receptors, the synthetic materials are able to communicate with cells. "Cellular receptors constantly move around," Stupp said. "By making our molecules move, 'dance' or even leap temporarily out of these structures, known as supramolecular polymers, they are able to connect more effectively with receptors."

Source: www.news-medical.net ↗
02How do you think studies on D-amino acids and their role in the human body are going to develop in the future?

This work is going to expand greatly. We are just at the very beginning and are still trying to convince people that it is important and something that should be studied. I think that battle is over, and now the great onslaught of research is about to begin. The roles of D-amino acids, whether they are free D-amino acids or in peptides and proteins, more and more are going to be discovered. This research is going to expand greatly. I think you will find a field, D-amino acid proteomics, which we are proposing, is going to grow tremendously.

Source: www.news-medical.net ↗
03Are supplements necessary?

Daily, if you eat a balanced diet that includes healthy foods, you technically should not need a vitamin supplement. A healthy diet incorporates lean proteins, healthy fats, grains, fruits, and vegetables. But if you do not have a balanced diet, you may be considering hair, skin, and nail vitamins. Some people prefer supplements, sometimes choosing a multivitamin that can supply all of your essential minerals and vitamins. But taking too much of vitamins or unnecessary supplements is wasteful because the body gets rid of excess vitamins and minerals or, worse, it can be dangerous. The following is a guide to choosing which vitamins you may want to consider supplementing and when. Deficiencies in the nutrients that keep the skin, hair, and nails healthy can cause changes over time. For example, not enough intake of vitamins A and E, along with not enough biotin, can cause scaly and rough skin patches, eczema, and hair loss. If there is a deficiency, vitamins will help. However, if there is no deficiency, there is no clear evidence that supplements will make a difference. No research studies concluded that supplements treat or prevent age-related, natural hair damage or loss or lead to healthier skin. Two studies in the early 1990s did suggest that a biotin supplement may cause the hair to become stronger and strengthen weak nails. However, the studies were small and not reproduced.

Source: www.medicinenet.com ↗
04Do BCAA Supplements Increase Muscle Mass?

There is mixed evidence regarding the effectiveness of BCAA supplements to increase muscle mass in its users. Research investigating such effects between those who took BCAA supplements and a placebo found that those who took the supplement reported increase energy metabolism and reduced levels of substances attributed to muscle damage. However, other researchers proposed there is a lack of consensus regarding the effects of BCAAs as a nutritional supplement. Despite disagreement in the scientific literature, it is indicated that potential overconsumption of BCAAs may pose health risks. However, more research is needed to further investigate the impact of both typical and excessive consumption.

Source: www.news-medical.net ↗
05How will this discovery change cancer science?

This is a win for the field. Until now, we have been focused on immune therapies that might make tumors more vulnerable to the body's immune system, and on finding new chemotherapy combinations that kill cancer cells. This new treatment has given us a new focus, and I think it will spur a lot of scientific discovery over the next few years. There have only been a handful of KRAS researchers and their relevance to therapy was always questioned. That is about to change. The most important next step for the field is to better understand the biology of cancer. We know that many pancreatic tumors will eventually become resistant to daraxonrasib, and we need to understand how this happens. We also need to identify additional genetic pathways and treatments that can target them. That's how we will turn pancreas cancer from a deadly, deadly cancer into something we can manage-and one day, even cure.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides